These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 34570694)

  • 1. Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021.
    Glatman-Freedman A; Hershkovitz Y; Kaufman Z; Dichtiar R; Keinan-Boker L; Bromberg M
    Emerg Infect Dis; 2021 Nov; 27(11):2919-2922. PubMed ID: 34570694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5-11 Years of Age, Israel.
    Glatman-Freedman A; Hershkovitz Y; Dichtiar R; Rosenberg A; Keinan-Boker L; Bromberg M
    Emerg Infect Dis; 2023 Apr; 29(4):771-777. PubMed ID: 36863005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents in Israel.
    Prunas O; Weinberger DM; Pitzer VE; Gazit S; Patalon T
    Clin Infect Dis; 2023 Jan; 76(1):113-118. PubMed ID: 36484301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel.
    Glatman-Freedman A; Bromberg M; Hershkovitz Y; Sefty H; Kaufman Z; Dichtiar R; Keinan-Boker L
    Emerg Infect Dis; 2022 May; 28(5):948-956. PubMed ID: 35361311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2.
    Levine-Tiefenbrun M; Yelin I; Alapi H; Katz R; Herzel E; Kuint J; Chodick G; Gazit S; Patalon T; Kishony R
    Nat Med; 2021 Dec; 27(12):2108-2110. PubMed ID: 34728830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization.
    Chodick G; Tene L; Patalon T; Gazit S; Ben Tov A; Cohen D; Muhsen K
    JAMA Netw Open; 2021 Jun; 4(6):e2115985. PubMed ID: 34097044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.
    Li XN; Huang Y; Wang W; Jing QL; Zhang CH; Qin PZ; Guan WJ; Gan L; Li YL; Liu WH; Dong H; Miao YT; Fan SJ; Zhang ZB; Zhang DM; Zhong NS
    Emerg Microbes Infect; 2021 Dec; 10(1):1751-1759. PubMed ID: 34396940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single dose of the Biontech/Pfizer BNT162b2 vaccine protected elderly residents from severe COVID-19 during a SARS-coronavirus-2 outbreak in a senior citizen home in Germany.
    Schwarzer R; Freys SD; Neuwinger N; Beikert N; Eberspächer B; Edelmann A; Zuchowski M; Slothouwer I; Stein A; Theil K; Menzel P; Hofmann J
    Immun Inflamm Dis; 2021 Dec; 9(4):1809-1814. PubMed ID: 34528766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of a Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis: Maricopa County, Arizona, June-July 2021.
    Dale AP; Almendares O; Howard BJ; Burnett E; Prasai S; Arons M; Collins J; Duffy N; Pandit U; Brady S; White JR; Garrett B; Kirking HL; Sunenshine R; Tate JE; Scott SE
    Clin Infect Dis; 2022 Aug; 75(1):e20-e26. PubMed ID: 35413107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants.
    Kislaya I; Rodrigues EF; Borges V; Gomes JP; Sousa C; Almeida JP; Peralta-Santos A; Nunes B;
    Emerg Infect Dis; 2022 Feb; 28(2):331-337. PubMed ID: 34876242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of the BNT162b2 vaccine during a COVID-19 nursing home outbreak.
    McEllistrem MC; Clancy CJ; Buehrle DJ; Lucas A; Pruskowski J; Handler SM; Decker BK
    Am J Infect Control; 2021 Oct; 49(10):1237-1241. PubMed ID: 34363871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.
    Loconsole D; Sallustio A; Accogli M; Leaci A; Sanguedolce A; Parisi A; Chironna M
    Clin Microbiol Infect; 2021 Aug; 27(8):1174.e1-1174.e4. PubMed ID: 33984489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection shortly after BNT162b2 vaccination results in high anti-spike antibody levels in nursing home residents and staff.
    Urlaub D; Wolfsdorff N; Durak D; Renken F; Watzl C
    Immun Inflamm Dis; 2021 Dec; 9(4):1702-1706. PubMed ID: 34499821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Outbreak of Breakthrough Infections by the SARS-CoV-2 Delta Variant in a Psychiatric Closed Ward.
    Wi YM; Kim SH; Peck KR
    J Korean Med Sci; 2022 Jan; 37(4):e28. PubMed ID: 35075827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of mRNA BNT162b2 Vaccine 6 Months after Vaccination among Patients in Large Health Maintenance Organization, Israel.
    Kertes J; Gez SB; Saciuk Y; Supino-Rosin L; Stein NS; Mizrahi-Reuveni M; Zohar AE
    Emerg Infect Dis; 2022 Feb; 28(2):338-346. PubMed ID: 34906291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by a Fourth Dose of BNT162b2 against Omicron in Israel.
    Bar-On YM; Goldberg Y; Mandel M; Bodenheimer O; Amir O; Freedman L; Alroy-Preis S; Ash N; Huppert A; Milo R
    N Engl J Med; 2022 May; 386(18):1712-1720. PubMed ID: 35381126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May-June 2021.
    Harris JR; Owusu D; O'Laughlin K; Cohen AL; Ben Hamida A; Patel JC; Freeman MM; Nsibambi T; Nieves R; Marston BJ; Wasike S; Galbraith JS; Boore AL; Nelson LJ; Guagliardo SAJ; Klena JD; Patel K; Ma M
    Emerg Infect Dis; 2022 Jun; 28(6):1279-1280. PubMed ID: 35470796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An outbreak of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infections among hospital personnel with high mRNA vaccine uptake.
    Tene Y; Levytskyi K; Adler A; Halutz O; Paran Y; Goldshmidt H; Itzhaki-Alfia A; Halperin T; Stepansky S; Ben-Ami R; Henig O
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):114-117. PubMed ID: 34538284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.